SHINE Medical Technologies, a Monona, Wisconsin-based medical isotope manufacturer, is now closer to producing molybdenum-99 (Mo-99) after receiving a new custom-designed production accelerator.

President Trump tweeted Oct. 18 that all Republicans support patients with pre-existing conditions, “and if they don’t, they will after I speak to them”—a sentiment that directly contradicts the Trump administration’s efforts to strip the Affordable Care Act of its protections for such patients.

The “flipped classroom” learning methodology proved to be a positive experience for fourth-year medical students at the University of California Riverside School of Medicine, according to new research published in the Journal of the American College of Radiology.

Today, Medical Group Management Association (MGMA) proudly announces its 2018-2019 Board of Directors.

The FDA rejected Norvartis’ bid to expand the indications for canakinumab to include cardiovascular risk reduction among heart attack survivors, Reuters reported Oct. 18.

Among women receiving radiation therapy to treat early-stage breast cancer, receiving larger individual doses was not associated with a significant increase in long-term side effects, according to a 10-year study presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Global Healthcare Exchange, LLC(GHX), a healthcare business and data automation company, has added two senior executives to support and amplify the company’s growth plans.

Radiation therapy can lower the chance of cancer recurrence in patients with low-risk breast cancer following breast conservation surgery, according to data presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.